FISPB
BCYC

Fideuram - Intesa Sanpaolo Private Banking’s Bicycle Therapeutics BCYC Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Hold
9
– – ﹤0.01% 446
2026
Q1 		$42 Sell
9
-134,680
-100% -$770K ﹤0.01% 459
2025
Q4 		$954K Buy
+134,689
New +$993K 0.03% 276

Other funds holding BCYC

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's BCYC Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 9 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in BCYC in Q4 2025 and has held it in 3 quarters since. The position peaked at $954K in Q4 2025. 32 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 9 shares of Bicycle Therapeutics worth $38 as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #446 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Bicycle Therapeutics position peaked at $954K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.